Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction
Fasiha Kanwal, Amit G. Singal
Gastroenterology (2019) Vol. 157, Iss. 1, pp. 54-64
Open Access | Times Cited: 396

Showing 51-75 of 396 citing articles:

Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK
Victoria Hamill, Will Gelson, Douglas MacDonald, et al.
Liver International (2023) Vol. 43, Iss. 4, pp. 917-927
Open Access | Times Cited: 13
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
Zhong-Chen Li, Jie Wang, He-Bin Liu, et al.
Cell Reports (2024) Vol. 43, Iss. 3, pp. 113877-113877
Open Access | Times Cited: 5
Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis
Nicola Schieda, Christian B. van der Pol, Daniel Walker, et al.
Radiology (2020) Vol. 297, Iss. 3, pp. 565-572
Closed Access | Times Cited: 37
A Prognostic Model of 15 Immune-Related Gene Pairs Associated With Tumor Mutation Burden for Hepatocellular Carcinoma
Junyu Huo, Liqun Wu, Yunjin Zang
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 34
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma
Yezhou Ding, Kehui Liu, Yumin Xu, et al.
Cancer Medicine (2020) Vol. 9, Iss. 9, pp. 3057-3069
Open Access | Times Cited: 33
Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
Daniel Roessler, Osman Öcal, Alexander Philipp, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3065-3073
Open Access | Times Cited: 21
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S207-S219
Open Access | Times Cited: 21
Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles
Han Deng, Wenting Shang, Kun Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 20
CT/MR detectable magnetic microspheres for self-regulating temperature hyperthermia and transcatheter arterial chemoembolization
Chengxiong Wei, Chengwei Wu, Xin Jin, et al.
Acta Biomaterialia (2022) Vol. 153, pp. 453-464
Closed Access | Times Cited: 19
Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
Darren Jun Hao Tan, Ansel Shao Pin Tang, Wen Hui Lim, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 445-456
Open Access | Times Cited: 12
A comprehensive evaluation of full-spectrum cell-free RNAs highlights cell-free RNA fragments for early-stage hepatocellular carcinoma detection
Chun Ning, Peng Cai, Xiaofan Liu, et al.
EBioMedicine (2023) Vol. 93, pp. 104645-104645
Open Access | Times Cited: 11
Construction of an immunosensor based on Cys/Au@TiO2 modification for the detection of liver cancer marker PIVKA-II
Lvhong Gong, Shengxi Wu, Junjie Liu, et al.
Talanta (2024) Vol. 275, pp. 126082-126082
Closed Access | Times Cited: 4
Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?
Emeka Agudile, Eduardo A. Vega, Oscar Salirrosas, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 9, pp. 1392-1399
Closed Access | Times Cited: 4
Application of dynamic enhanced scanning with GD-EOB-DTPA MRI based on deep learning algorithm for lesion diagnosis in liver cancer patients
Bo Liu, Jinhua Yang, Yifei Wu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Predicting hepatocellular carcinoma survival with artificial intelligence
İsmet Seven, Bayram Doğan, Hilal Arslan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hepatocellular carcinoma: what are the differential costs compared to the general population?
Josep Darbà, Meritxell Ascanio
Journal of Medical Economics (2025), pp. 1-15
Open Access
Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abé, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1865-1865
Open Access | Times Cited: 35
Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis
Peter Jepsen, Frederik Kraglund, Joe West, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1030-1036
Open Access | Times Cited: 29
The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
Jie Zhu, Peiqi Fang, Chong Wang, et al.
Cancer Medicine (2021) Vol. 10, Iss. 22, pp. 7977-7987
Open Access | Times Cited: 26
Chronic Hepatitis B Infection with Low Level Viremia Correlates with the Progression of the Liver Disease
Qian Zhang, Xiaozhong Peng, Xiaoqing Liu, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 25
Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases
Eirini I. Rigopoulou, George N. Dalekos
Cancers (2021) Vol. 13, Iss. 5, pp. 1023-1023
Open Access | Times Cited: 24
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
Hamish Innes, Peter Jepsen, Scott McDonald, et al.
JHEP Reports (2021) Vol. 3, Iss. 6, pp. 100384-100384
Open Access | Times Cited: 24
6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway
Changzheng Li, Jie Chen, Yishan Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 24
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
Tin Nadarević, Agostino Colli, Vanja Giljača, et al.
Cochrane library (2022) Vol. 2022, Iss. 5
Open Access | Times Cited: 17
Clinical practice guidelines on hemochromatosis: Asian Pacific Association for the Study of the Liver
Dorothy H. Crawford, Grant A. Ramm, Kim R. Bridle, et al.
Hepatology International (2023) Vol. 17, Iss. 3, pp. 522-541
Open Access | Times Cited: 10

Scroll to top